Protein synthesis inhibitor omacetaxine is effective against hepatocellular carcinoma.
Jci Insight
Li, Ling L; Halpert, Gilad G; Lerner, Michael G MG; Hu, Haijie H; Dimitrion, Peter P; Weiss, Matthew J MJ; He, Jin J; Philosophe, Benjamin B; Burkhart, Richard R; Burns, William R WR; Wesson, Russell N RN; MacGregor Cameron, Andrew A; Wolfgang, Christopher L CL; Georgiades, Christos C; Kawamoto, Satomi S; Azad, Nilofer S NS; Yarchoan, Mark M; Meltzer, Stephen J SJ; Oshima, Kiyoko K; Ensign, Laura M LM; Bader, Joel S JS; Selaru, Florin M FM
BET proteolysis targeted chimera-based therapy of novel models of Richter Transformation-diffuse large B-cell lymphoma.
Leukemia
Fiskus, Warren W; Mill, Christopher P CP; Perera, Dimuthu D; Birdwell, Christine C; Deng, Qing Q; Yang, Haopeng H; Lara, Bernardo H BH; Jain, Nitin N; Burger, Jan J; Ferrajoli, Alessandra A; Davis, John A JA; Saenz, Dyana T DT; Jin, Wendy W; Coarfa, Cristian C; Crews, Craig M CM; Green, Michael R MR; Khoury, Joseph D JD; Bhalla, Kapil N KN
Genetic modification of primary human B cells to model high-grade lymphoma.
Nature Communications
Caeser, Rebecca R; Di Re, Miriam M; Krupka, Joanna A JA; Gao, Jie J; Lara-Chica, Maribel M; Dias, João M L JML; Cooke, Susanna L SL; Fenner, Rachel R; Usheva, Zelvera Z; Runge, Hendrik F P HFP; Beer, Philip A PA; Eldaly, Hesham H; Pak, Hyo-Kyung HK; Park, Chan-Sik CS; Vassiliou, George S GS; Huntly, Brian J P BJP; Mupo, Annalisa A; Bashford-Rogers, Rachael J M RJM; Hodson, Daniel J DJ
Publication Date: 2019-10-04
Variant appearance in text: ARID1A: 3589T>C; Ser1197Pro